News
OCRA-Funded Study Points to New Approach to Improve Ovarian Cancer Treatment
The following is a press release from University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, and Magee-Womens Research Institute PITTSBURGH, Nov…
Exercise and Ovarian Cancer
Physical activity has been touted as important for a whole host of reasons, from bone health to mental health and everything in between…
Small Cell Carcinoma Hypercalcemic Type | Heather’s #RareAware Story
Heather lives in Muskegon, and was diagnosed with small cell carcinoma, hypercalcemic type. What has been your frustration in having a rare form of ovarian cancer? My local doctors shoved it off as pregnancy symptoms or being a hypochondriac…
The Overview: October 2021
Have we got a roundup in store! You heard from us a lot in September (thanks to you, we surpassed our Ovarian Cancer Awareness Month fundraising goal!) and there’s still so much to report … research progress, a brand new clinical trial…
When You Don’t Fit the Profile for a Women’s Cancer | Survivor Stories
B. Dana Kivel has a plea to the ovarian cancer community, to medical professionals, to the world: “See me. Listen to me. I’m one of the people, the tens of thousands of people who have metastatic ovarian cancer…
Study Finds Germline Ovarian Cancer Mutations Occur Equally in Black and White Patients
A recent study has shed more light on the demographics of hereditary ovarian cancer, and provides further data to suggest an urgent need for increased genetic counseling for potentially high-risk Black women, as well as increased genetic testing in…
Join Us: OCRA’s Virtual Fall Advocacy Day
November 15-16, 2021 | Register Today! Are you passionate about issues affecting the ovarian cancer community? Now is your chance to have your voice heard at the highest levels — without ever leaving home! OCRA’s Virtual Advocacy Day is a…
Giving It Their All for a Common Goal | Heroes Highlights
At first glance, Jonathan Sockolosky and Andrew Berger, may seem like they have very little in common. Jonathan lives in San Francisco and is a scientist, while Andrew lives in New York, and works in the finance industry…
Finding the Story in the Data | Meet a Scientist
Sridevi Challa, PhD, an OCRA grantee at UT Southwestern, is on the receiving end of some major accolades…
OCRA-Funded Study Identifies Role of Deubiquitinating Enzyme in Ovarian Cancer Progression
OCRA grantee Dr. Sumegha Mitra of Indiana University and colleagues have identified the mechanism by which a specific deubiquitinating enzyme known as UCHL1 promotes the growth of high-grade serous ovarian cancer in some patients…
Groundbreaking Initiative Seeks to Accelerate Development of New Treatments with OCRA’s Support
LOS ANGELES – (BUSINESS WIRE)–Global Coalition for Adaptive Research (GCAR) announces a new clinical trial initiative, Ovarian CanceRxTM…
Survey: Medical Care During COVID
OCRA is conducting a survey to gauge patient response to the expansion of telehealth in response to the pandemic. Since the onset of the COVID-19 pandemic, telehealth has been growing in popularity…